Genentech RTP Biomanufacturing Facility

Holly Springs, North Carolina, United States

Genentech's RTP Biomanufacturing Facility is a state-of-the-art, 700,000-square-foot industrial complex located in Holly Springs, North Carolina, within the Research Triangle Park region. Designed to produce next-generation metabolic medicines, including treatments for obesity and heart disease, the facility represents Genentech's first major East Coast manufacturing investment. Its strategic location leverages proximity to leading life sciences companies, top research institutions, and a highly skilled workforce, reinforcing Holly Springs as a pivotal hub for biotech innovation. The facility is currently under construction, with completion and operational launch targeted for 2029.